P/B
2,5
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
$6.4B
Market Cap • 10/2/2026
2015
(11 years)
Founded
2024
(2 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
38,7
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
56,9
EPS
—
Market Cap
Market Cap
6,4B
EV
5,6B
EV/Revenue
34,1
EV/EBITDA
-13,9
EV/EBIT
-10,1
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,1%
Total Yield
-0,1%
Payout
0%
Retained Earnings
-10,4B
Profitability
Gross Margin
49,7%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
115,6%
Capex/Revenue
0,9%
Capex/D&A
0,9%
Capex/OCF
-0,5%
SBC/OCF
—
% PPE
4,7%
% Goodwill
0%
ROE
—
ROIC
—
Leverage
N.D./EBITDA
1,9
Debt/Equity
0%
Current Ratio
10,9
Quick Ratio
10,6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!